Tech Company Financing Transactions
Seventh Sense Biosystems Funding Round
Seventh Sense Biosystems secured a $4.5 million Series A funding round on 5/11/2011. Investors included Flagship Pioneering, Polaris Partners and Third Rock Ventures.
Transaction Overview
Company Name
Announced On
5/11/2011
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Series A
Investors
Proceeds Purpose
The funds will be used to advance development of the TAP platform, which enables one-step blood collection in a safe, painless and convenient manner.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
200 Boston Ave. 3700
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Website
Email Address
Overview
The company's proprietary TAP Touch Activated Phlebotomy technology enables painless, convenient and safe blood collection and is the foundation for a rich pipeline of products from painless, one-step sampling to integrated collection and analysis for a total decentralized testing solution
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harry Wilcox
Chief Operating Officer
Timothy Richards
Chief Scientific Officer
Howard Bernstein
VP - Bus. Development
Stuart Blitz
VP - Engineering
Jerry Brightbill
Browse more venture capital transactions:
Prev: 5/11/2011: Wavemark venture capital transaction
Next: 5/11/2011: LearnBoost venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs